🇺🇸 FDA
Patent

US 10813885

Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

granted A61KA61K31/19A61K9/2054

Quick answer

US patent 10813885 (Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances) held by Jazz Pharmaceuticals, Inc. expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals, Inc.
Grant date
Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/19, A61K9/2054, A61K9/209, A61K9/2833